| 4534 |
Centers for Disease Control and Prevention |
Html |
en |
HIV/AIDS and the Flu |
People with HIV/AIDS are at increased risk of from serious complications from flu - CDC |
| influenza infection | 0.501945 |
| influenza antiviral agents | 0.63814 |
| influenza antiviral drugs | 0.667501 |
| influenza-related complications | 0.515811 |
| HIV-infected persons | 0.42386 |
| influenza symptoms | 0.516587 |
| ) site. | 0.403636 |
| HIV attacks cells | 0.495183 |
| antiviral chemoprophylaxis agents | 0.423702 |
| example people | 0.271816 |
| influenza vaccine | 0.772204 |
| seasonal influenza | 0.451262 |
| Current CDC guidance | 0.339385 |
| certain cancers | 0.257269 |
| AIDS | 0.324424 |
| lung-related hospitalizations | 0.258934 |
| flu antiviral drugs | 0.607227 |
| severe paralyzing illness | 0.35283 |
| active antiretroviral therapy | 0.382402 |
| life-threatening allergic reaction | 0.355979 |
| adverse drug reactions | 0.339672 |
| inactivated influenza vaccine | 0.708354 |
| live influenza virus | 0.579897 |
| high risk | 0.524724 |
| human immunodeficiency virus | 0.401732 |
|
| antiviral medications | 0.468161 |
| advanced HIV disease | 0.466354 |
| influenza | 0.945315 |
| milder egg allergies | 0.357093 |
| United States | 0.261501 |
| flu vaccine | 0.692463 |
| flu complications | 0.533244 |
| certain people | 0.294613 |
| flu shots | 0.448588 |
| immune response | 0.399622 |
| immunodeficiency syndrome | 0.269297 |
| health care workers | 0.515621 |
| influenza season | 0.515875 |
| greater chance | 0.360241 |
| certain HIV-infected people | 0.492132 |
| people | 0.703661 |
| influenza vaccination | 0.628795 |
| flu | 0.81856 |
| local public health | 0.337326 |
| nasal spray vaccine | 0.430377 |
| flu shot | 0.452227 |
| HIV | 0.586511 |
| influenza viruses | 0.510023 |
| poor immune response | 0.373602 |
|
CLICK HERE |
| 4690 |
Centers for Disease Control and Prevention |
Html |
en |
Commute times, food retail gaps, and body mass index in North Carolina counties |
null |
| North Carolina | 0.448328 |
| commute time | 0.390185 |
| rural residents | 0.380633 |
| North Carolina Department | 0.21281 |
| special food services | 0.206743 |
| county-level independent variables | 0.201504 |
| county-level food sales | 0.226185 |
| individual-level bmi | 0.282425 |
| county-level variables | 0.21118 |
| mean county-level commute | 0.262666 |
| county-level BMI | 0.272693 |
| county-level mean BMI | 0.318146 |
| longer commute times | 0.221117 |
| BMI | 0.325295 |
| average commute time | 0.208621 |
|
| drinking places | 0.245558 |
| commute times | 0.635556 |
| NAICS code | 0.211841 |
| specialty food stores | 0.222786 |
| county-level sales | 0.221783 |
| food retail gap | 0.925332 |
| county-level retail sales | 0.206841 |
| county-level commute time | 0.290969 |
| North Carolina counties | 0.274497 |
| county-level commute times | 0.355083 |
| food retail gaps | 0.320831 |
| county-level diversity index | 0.20896 |
| county-level demand | 0.231366 |
| capita | 0.273709 |
|
CLICK HERE |
| 6526 |
Centers for Disease Control and Prevention |
Html |
en |
Key Facts about Human Infections with Variant Viruses (Swine Origin Influenza Viruses in Humans) |
Key Facts about Human Infections with Variant Viruses (Swine Origin Influenza Viruses in Humans) - CDC |
| type A influenza | 0.386903 |
| swine influenza virus | 0.591329 |
| novel viruses | 0.275777 |
| variant flu viruses | 0.43509 |
| swine industry | 0.235236 |
| H3N2 virus | 0.216854 |
| Mortality Weekly Report | 0.206511 |
| United States | 0.206038 |
| variant influenza virus. | 0.460632 |
| human influenza viruses | 0.616197 |
| swine herds | 0.247966 |
| CDC Seasonal Influenza | 0.378394 |
| infected swine | 0.283659 |
| infected pigs | 0.252116 |
| influenza-infected pigs | 0.229355 |
| pigs | 0.34685 |
| Variant Influenza Viruses | 0.5677 |
| variant influenza virus | 0.470507 |
| Swine flu viruses | 0.537581 |
| variant viruses | 0.434956 |
| exhibits housing pigs | 0.246732 |
| human-to-human transmission | 0.201732 |
| swine origin influenza | 0.491657 |
| influenza A virus | 0.377467 |
|
| novel influenza virus | 0.457123 |
| influenza vaccines | 0.350998 |
| seasonal influenza | 0.484044 |
| influenza pandemic | 0.355698 |
| influenza virus infections | 0.600287 |
| Yes. Swine flu | 0.308289 |
| variant viruses. | 0.20184 |
| human seasonal influenza | 0.401157 |
| people | 0.252521 |
| influenza A H1N1 | 0.345369 |
| seasonal flu transmits | 0.21559 |
| pandemic preparedness efforts | 0.208144 |
| human infections | 0.305787 |
| new virus | 0.256025 |
| limited person-to-person spread | 0.212188 |
| influenza viruses | 0.964527 |
| sick pigs | 0.267213 |
| influenza virus | 0.720951 |
| variant virus infections | 0.355254 |
| infect pigs | 0.213257 |
| U.S. Human Infections | 0.238789 |
| state level surveillance | 0.200564 |
| influenza a h3n2 | 0.391627 |
|
CLICK HERE |
| 6954 |
Centers for Disease Control and Prevention |
Html |
en |
CDC - Preventing Chronic Disease: Volume 9, 2012:11_0142 |
In Ethiopia, lack of reliable data on causes of death prevents full understanding of the double mortality burden of communicable and noncommunicable diseases. Our objective was to help bridge this research gap by analyzing surveillance data on causes of death in Addis Ababa. |
| epidemiological transition | 0.450659 |
| verbal autopsy interviews | 0.378409 |
| injuries | 0.397193 |
| premature death rate | 0.37135 |
| female deaths | 0.468894 |
| major causes | 0.37466 |
| World Bank | 0.382656 |
| standardized verbal autopsy | 0.377378 |
| deaths | 0.79482 |
| group | 0.432318 |
| burial surveillance records | 0.369716 |
| adult death rates | 0.382466 |
| World Health Organization | 0.412216 |
| digestive tract diseases | 0.582305 |
| Addis Ababa | 0.988385 |
| verbal autopsies | 0.530933 |
| verbal autopsy questionnaire | 0.412811 |
| Mortality Surveillance Program | 0.455029 |
| overall death rates | 0.38049 |
| Addis Ababa population | 0.49409 |
| death rates | 0.426895 |
| age-specific death rate | 0.381623 |
| Addis Ababa residents | 0.532789 |
| Ethiopia | 0.368765 |
| study | 0.453291 |
|
| death | 0.62983 |
| age group | 0.418825 |
| adults | 0.421231 |
| Addis Ababa Labour | 0.470651 |
| communicable diseases | 0.682389 |
| Addis Ababa University | 0.472553 |
| death rate | 0.395994 |
| typical mortality burden | 0.371307 |
| Premature deaths | 0.44455 |
| burial surveillance | 0.544258 |
| verbal autopsy | 0.492162 |
| causes | 0.508537 |
| premature death increases | 0.373169 |
| double mortality burden | 0.591632 |
| Addis Ababa Mortality | 0.543086 |
| Ababa Mortality Surveillance | 0.512489 |
| noncommunicable diseases | 0.914211 |
| CVD deaths | 0.417503 |
| Addis Ababa cemeteries | 0.489058 |
| adult deaths | 0.442934 |
| deceased Addis Ababa | 0.495084 |
| infant deaths | 0.41306 |
| malignant neoplasm | 0.413019 |
| proportional death rates | 0.3817 |
|
CLICK HERE |
| 9339 |
Centers for Disease Control and Prevention |
Html |
es |
Reducción de enfermedades cardiovasculares mediante guías de pacientes, Denver, Colorado, 2007-2009 |
null |
| Task Force | 0.439066 |
| posibles participantes | 0.590717 |
| Prev Med | 0.608006 |
| Increasing physical activity | 0.439606 |
| D’Agostino RB | 0.444649 |
| cardiovascular health promotion | 0.435488 |
| risk factors | 0.555447 |
| colesterol hdl | 0.637464 |
| colesterol ldl | 0.541493 |
| Kannel WB | 0.441261 |
| community health | 0.487639 |
| community health workers | 0.481655 |
| Denver Public Health | 0.443907 |
| Hospital Authority | 0.434563 |
| coronary heart | 0.623273 |
| salud comunitaria | 0.448033 |
| baja densidad | 0.488624 |
| Battaglia TA | 0.438665 |
| Public Health | 0.453172 |
| referenciaa periodo | 0.439137 |
| Wilson PW | 0.437098 |
| alto riesgo | 0.446644 |
| puntuación frs | 0.9552 |
| disease risk | 0.523207 |
| vasculopatÃa periférica | 0.511662 |
|
| mm hg | 0.44637 |
| physical activity questionnaire | 0.437454 |
| CaracterÃsticas Periodo | 0.464339 |
| Gen Intern Med | 0.582757 |
| alta densidad | 0.635437 |
| Salud Pública | 0.532261 |
| Patient navigation | 0.480286 |
| bajos ingresos | 0.498242 |
| Intern Med | 0.655953 |
| aórtico abdominal | 0.447994 |
| Sullivan LM | 0.44187 |
| modifiable risk factors | 0.43532 |
| cardiopatÃa coronaria | 0.662293 |
| Arch Intern Med | 0.440705 |
| Denver Health | 0.462548 |
| presente intervención | 0.512404 |
| physical activity | 0.606014 |
| caracterÃsticas clÃnicas | 0.534321 |
| health center | 0.481708 |
| absolute cardiovascular risk | 0.438053 |
| mejorÃas significativas | 0.459824 |
| Community Preventive Services | 0.472714 |
| primary care | 0.443791 |
| puntuación frs frente | 0.449823 |
|
CLICK HERE |
| 10573 |
Centers for Disease Control and Prevention |
Html |
en |
Search the NIOSH Website |
null |
| NIOSH Research Rounds | 0.715365 |
| NIOSH Milestones | 0.609882 |
| NIOSH History | 0.611473 |
| Health Workforce Assessment | 0.201582 |
| NIOSH Programs | 0.651395 |
| Search Form Controls | 0.381327 |
| NIOSH Homepage | 0.712037 |
| Contact NIOSH | 0.809963 |
| NIOSH A-Z Index | 0.778422 |
| Contact NIOSH Add | 0.673955 |
| Worker Health Study | 0.203643 |
| Health Topics | 0.260642 |
| Workplace Safety | 0.251271 |
| National Occupational Safety | 0.222819 |
| NIOSH Advisory Committees | 0.697839 |
|
| occupational safety | 0.459645 |
| Search Controls | 0.229884 |
| page options Skip | 0.22406 |
| Health Effects Laboratory | 0.20448 |
| NIOSH Website | 0.908723 |
| Construction Occupational Safety | 0.201871 |
| NIOSH Science Blog | 0.694829 |
| NIOSH Goals | 0.612192 |
| FRN Archive | 0.514051 |
| Respiratory Health Division | 0.21987 |
| Search NIOSHTIC-2 Research | 0.24005 |
| NIOSH Centers | 0.643782 |
| NIOSH Awards | 0.615479 |
| Notices FRN Archive | 0.208056 |
|
CLICK HERE |
| 13201 |
Centers for Disease Control and Prevention |
Html |
en |
Announcement: CDC-Sponsored Continuing Education Courses onScreening for Colorectal Cancer |
Colorectal cancer is the second leading cancer killer in the United States. Screening for colorectal cancer saves lives, but problems with its implementation in clinical practice can reduce screening's effectiveness. |
| CDC-sponsored continuing education | 0.648923 |
| endorsement | 0.399693 |
| Human Services | 0.637746 |
| leaders | 0.329283 |
| research | 0.329228 |
| U.S. Department | 0.632227 |
| MMWR HTML versions | 0.622939 |
| primary care providers | 0.642609 |
| education credits | 0.481567 |
| physicians | 0.328979 |
| electronic PDF version | 0.602772 |
| colorectal cancer screening | 0.798357 |
| health professionals | 0.490799 |
| courses | 0.357828 |
| colorectal cancer | 0.980273 |
| lives | 0.332273 |
| Contact GPO | 0.514566 |
| maximum benefit | 0.480483 |
| patients | 0.33008 |
| commercial sources | 0.477806 |
| primary care clinicians | 0.683504 |
| current prices | 0.467503 |
| original paper copy | 0.599882 |
| problems | 0.332244 |
|
| best ways | 0.488882 |
| nationally recognized experts | 0.631776 |
| United States | 0.503722 |
| U.S. Government Printing | 0.600959 |
| clinical practice | 0.501541 |
| Superintendent | 0.334044 |
| tools | 0.330219 |
| MMWR readers | 0.484208 |
| character translation | 0.46652 |
| MMWR paper copy | 0.612345 |
| course | 0.3298 |
| format errors | 0.473712 |
| effectiveness | 0.329715 |
| colonoscopy procedures | 0.501572 |
| implementation | 0.332215 |
| typeset documents | 0.480424 |
| public health programs | 0.646845 |
| trade names | 0.477975 |
| official text | 0.463841 |
| cancer killer | 0.518773 |
| non-CDC sites | 0.475306 |
| http://www.cdc.gov/cancer/colorectal/quality | 0.329565 |
| electronic conversions | 0.466122 |
| printable versions | 0.464393 |
|
CLICK HERE |
| 13370 |
Centers for Disease Control and Prevention |
Html |
en |
Information for Health Care Workers | Rat-bite Fever (RBF) |CDC |
null |
| Spirillum minus | 0.592867 |
| diagnosis assistance | 0.349598 |
| gram-negative microaerophilic bacillus | 0.590191 |
| pleomorphic gram-negative bacilli | 0.529052 |
| North America | 0.383047 |
| rodent exposure | 0.380331 |
| rat-bite fever | 0.524699 |
| Recent case reports | 0.472357 |
| severe nausea/vomiting | 0.36162 |
| RBF | 0.992699 |
| characteristic spirochetes | 0.364356 |
| Streptobacillus moniliformis | 0.566834 |
| body fluids | 0.348574 |
| infected rodent | 0.408287 |
| incidence rates | 0.357316 |
| preliminary diagnosis | 0.352634 |
| state public health | 0.46335 |
| maculopapular rash | 0.402834 |
| distinct rash | 0.394079 |
| Person-to-person transmission | 0.374664 |
| nationally notifiable disease | 0.47721 |
| normal respiratory flora | 0.519663 |
| United States | 0.345649 |
| natural reservoir | 0.364429 |
| appropriate specimens | 0.464556 |
|
| Haverhill fever | 0.754032 |
| rodent species | 0.397142 |
| S. moniliformis | 0.937049 |
| Accurate data | 0.346047 |
| incubation period | 0.378627 |
| differential stains | 0.34583 |
| motile spirochete | 0.413623 |
| S. minus | 0.420297 |
| incubation conditions | 0.362119 |
| fever onset | 0.478596 |
| red plaques | 0.353843 |
| potential risk | 0.34816 |
| untreated RBF | 0.69899 |
| common symptoms | 0.361821 |
| mortality rate | 0.348635 |
| Following partial healing | 0.476928 |
| positive culture | 0.34776 |
| disease incidence | 0.356641 |
| rat bite | 0.361391 |
| synovial fluid | 0.351658 |
| Initial symptoms | 0.366155 |
| infected animal | 0.365841 |
| specific media | 0.349932 |
| darkfield microscopy | 0.343958 |
|
CLICK HERE |
| 16169 |
Centers for Disease Control and Prevention |
Html |
en |
HPV Vaccine Information For Young Women |
HPV - STD information from CDC. Fact Sheets, Statistics, Treatment Guidelines, Resources for Clinicians and Educators. |
| HPV types— | 0.203411 |
| HPV vaccination | 0.344921 |
| HPV test | 0.237064 |
| HPV vaccine | 0.80765 |
| HPV types | 0.486735 |
| cervical cancer | 0.691177 |
| targeted HPV types | 0.242999 |
|
| HPV | 0.931484 |
| genital warts | 0.28749 |
| Genital HPV | 0.246161 |
| HPV infection | 0.23045 |
| HPV vaccines | 0.211736 |
| HPV infections | 0.202104 |
|
CLICK HERE |
| 16460 |
Centers for Disease Control and Prevention |
Html |
en |
Characteristics of Electronic Cigarette Use Among Middle andHigh School Students - United States, 2015 | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| e-cigarette advertising | 0.386574 |
| complex survey design | 0.383411 |
| conventional cigarettes | 0.381949 |
| multiple device types | 0.379791 |
| e-cigarette brands | 0.406684 |
| comprehensive tobacco control | 0.455588 |
| product types | 0.46234 |
| nicotine exposure | 0.426682 |
| U.S. Surgeon General | 0.386633 |
| commonly used e-cigarette | 0.45294 |
| response rate | 0.3836 |
| tobacco product dependence | 0.394422 |
| tobacco products | 0.456261 |
| public health practice | 0.392917 |
| commonly reported brand | 0.497195 |
| prevention strategies | 0.378352 |
| e-cigarette product types | 0.425031 |
| Connecticut high school | 0.391616 |
| U.S. middle | 0.520845 |
| United States | 0.438236 |
| Drug Administration | 0.389259 |
| youths | 0.611918 |
| products | 0.458892 |
| Hispanic students | 0.398656 |
|
| nicotine delivery | 0.396715 |
| nationally representative sample | 0.38035 |
| U.S. students | 0.378488 |
| tobacco product | 0.633647 |
| brands | 0.43107 |
| middle school students | 0.427365 |
| substances | 0.384343 |
| rechargeable/refillable e-cigarettes | 0.53826 |
| e-cigarette users | 0.440235 |
| commonly reported brands | 0.421561 |
| certain e-cigarette marketers | 0.400269 |
| high school students | 0.982371 |
| e-cigarettes | 0.820511 |
| National Youth Tobacco | 0.402011 |
| U.S. youths | 0.533109 |
| Nicotine content | 0.391399 |
| relative standard error | 0.380805 |
| commonly used tobacco | 0.573958 |
| high school students.* | 0.401242 |
| Table). | 0.39851 |
| NYTS response rate | 0.380165 |
| disposable e-cigarettes | 0.44469 |
| heavily advertised e-cigarette | 0.402367 |
| non-Hispanic black students | 0.48868 |
|
CLICK HERE |